These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 36217308)

  • 1. Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules.
    Tang J; Liu F; Cooper ME; Chai Z
    Expert Opin Ther Targets; 2022 Aug; 26(8):721-738. PubMed ID: 36217308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to inhibit transforming growth factor beta safely in diabetic kidney disease.
    Yang Y; Shi K; Patel DM; Liu F; Wu T; Chai Z
    Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):115-122. PubMed ID: 33229911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanistic Pathways Targeted by Natural Compounds in the Prevention and Treatment of Diabetic Kidney Disease.
    Zhou K; Zi X; Song J; Zhao Q; Liu J; Bao H; Li L
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
    Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
    Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming Growth Factor-Beta1 in Diabetic Kidney Disease.
    Zhao L; Zou Y; Liu F
    Front Cell Dev Biol; 2020; 8():187. PubMed ID: 32266267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysaccharides from Dendrobium officinale delay diabetic kidney disease interstitial fibrosis through LncRNA XIST/TGF-β1.
    Zhang Y; Deng Y; Yang Y; Yang Z; Yin Y; Xie J; Ding J; Shang Y; Zha Y; Yuan J
    Biomed Pharmacother; 2024 Jun; 175():116636. PubMed ID: 38677245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
    Zheng W; Guo J; Liu ZS
    Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of inflammation in diabetic kidney disease.
    Jung SW; Moon JY
    Korean J Intern Med; 2021 Jul; 36(4):753-766. PubMed ID: 34237822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ChREBP Deficiency Suppresses Renal Inflammation and Fibrosis Via Inhibiting NLRP3 Inflammasome Activation in Diabetic Kidney Disease.
    Chen N; Yang Z; Mu L; Wu M; Song J; Zhou T; Shi Y
    Discov Med; 2022; 33(169):69-83. PubMed ID: 36274225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-octyl itaconate inhibits high glucose induced renal tubular epithelial cell fibrosis through TGF-β-ROS pathway.
    Zou X; Wu M; Tu M; Tan X; Long Y; Xu Y; Li M
    J Recept Signal Transduct Res; 2024 Feb; 44(1):27-34. PubMed ID: 38660706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs.
    Sakuma H; Hagiwara S; Kantharidis P; Gohda T; Suzuki Y
    Front Pharmacol; 2020; 11():587689. PubMed ID: 33364960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage inflammatory protein-1β as a novel therapeutic target for renal protection in diabetic kidney disease.
    Chang TT; Li SY; Lin LY; Chen C; Chen JW
    Biomed Pharmacother; 2023 May; 161():114450. PubMed ID: 36863097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Cell Division Autoantigen 1 (CDA1) in Renal Fibrosis of Diabetic Nephropathy.
    Chen L; Wu J; Hu B; Liu C; Wang H
    Biomed Res Int; 2021; 2021():6651075. PubMed ID: 33997036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances.
    Watanabe K; Sato E; Mishima E; Miyazaki M; Tanaka T
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerobic exercise training alleviates renal injury in db/db mice through inhibiting Nox4-mediated NLRP3 inflammasome activation.
    Zhou Z; Ying C; Zhou X; Shi Y; Xu J; Zhu Y; Wang M; Li Y; Li X; Xiang J
    Exp Gerontol; 2022 Oct; 168():111934. PubMed ID: 36007721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis?
    Nguyen TQ; Goldschmeding R
    Pharm Res; 2008 Oct; 25(10):2416-26. PubMed ID: 18266088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
    Wang S; Denichilo M; Brubaker C; Hirschberg R
    Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.
    Lan HY
    Int J Biol Sci; 2011; 7(7):1056-67. PubMed ID: 21927575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis.
    Sun J; Wang Y; Cui W; Lou Y; Sun G; Zhang D; Miao L
    J Diabetes Res; 2017; 2017():7242384. PubMed ID: 28695133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives.
    Wang Y; Jin M; Cheng CK; Li Q
    Front Endocrinol (Lausanne); 2023; 14():1238927. PubMed ID: 37600689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.